Stocks · Health care · Biological Products, (No Diagnostic Substances)

Lexeo Therapeutics, Inc.

LXEO Clue Score11
United States Fiscal year ends December CIK 0001907108 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Paula H Cholmondeley
25 Nov 2024
Director
Buy
15,000
$6.99
$104.85K
Longitude Capital Partners IV, LLC
7 Nov 2023
10% owner
Buy indirect
454,545
$11.00
$5.00M
Invest A/S Lundbeckfond
7 Nov 2023
10% owner
Buy
227,272
$11.00
$2.50M
Omega Fund VI, L.P.
7 Nov 2023
10% owner
Buy
454,545
$11.00
$5.00M

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 10
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 6,496,115
History held since 9 Nov 2023